t-plasminogen activator inhibitor-1 polymorphism in idiopathic pulmonary arterial hypertension

Indian Journal of Human Genetics

Volumn 14, Issue 2, 2008, Pages 37-40

  Katta, Sujana ^a   Vadapalli, Shivani ^a   Sastry, Bks ^b   Nallari, Pratibha ^a  

^a OSMANIA UNIVERSITY   (India)

^b CARE HOSPITAL   (India)

Author keywords

Fibrinolytic pathway; Idiopathic pulmonary arterial hypertension; Plasminogen activator inhibitor 1; Thrombosis; Tissue remodeling Introduction

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN;

3' UNTRANSLATED REGION; ALLELE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FIBRINOLYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEART RIGHT VENTRICLE; HUMAN; IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION; LUNG ARTERY PRESSURE; LUNG BLOOD FLOW; LUNG PARENCHYMA; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; PLASMINOGEN ACTIVATION; POLYMERASE CHAIN REACTION; PULMONARY HYPERTENSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; THROMBOSIS; UPREGULATION;

EID: 56749159529     PISSN: 09716866     EISSN: 19983611     Source Type: Journal    
DOI: 10.4103/0971-6866.44103     Document Type: Article

References (15)

1. Hassell KL. Altered hemostasis in pulmonary hypertension. Blood Coag Fibrinolysis 1998;9:107-17.
2. Welsh CH, Hassell KL, Badesch DB, Kressin DC, Marlar. Coagulation and fibrinolytic profiles in patients with severe pulmonary hypertension. Chest 1996;110:710-7.
3. Kruithof EKO. Plasminogen activator inhibitors-A review. Enzyme 1988:40:113.
4. Andreasen PA, George B, Lund LR, Riccio A, Stacey SN. Plasminogen activator inhibitors: Hormonally regulated serpins. Mol Cell Endocrinol 1990;68:1-19.
5. Dawson SJ, Hamsten A, Wiman B, Henney A, Humphries S. Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. Arterioscler Thromb 1991;11:183-90.
6. Grenett HE, Benza RL, Li XN, Hines RB, Reeder VC, Brown SL, et al. Expression of plasminogen activator inhibitor type I in genotyped human endothelial cell cultures: Genotype-specific regulation by insulin. Circulation 1996;94:I-51.
7. Raymond L. Benza, M.D. Association of a Gene Polymorphism for PAI-1 with Primary Pulmonary Hypertension. Cardiopul and Critic Care Newsletter; 2002. p. 7-9.
8. Benza RL, Grenett HE, Bourge RC, Kirklin JK, Naftel DC, Castro PF, et al. Gene polymorphisms for plasminogen activator inhibitor-1/tissue plasminogen activator and development of allograft coronary artery disease. Circulation 1998;98:2248-54.
9. Crowther MA, Roberts J, Roberts R, Johnston M, Stevens P, Skingley P, et al. Fibrinolytic variables in patients with recurrent venous thrombosis: A prospective cohort study. Thromb Haemost 2001;85:390-4.
10. Lahiri DK, Nurnberger JI Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acid Res 1991;19:5444.
11. Falchi A, Vacca L, Alomar AL, Esteban E, Memmi M, Varesi L, et al. Population variability in some genes involving the haemostatic system: Data on the general population of Corsica (France), Sardinia and Sicily (Italy). Genet Mol Bio 2004;27:139-46.
12. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM. Direct binding of Smad 3 and Smad 4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. Embo J 1998;17:3091-100.
13. Runo JR, Loyd JE. Primary pulmonary hypertension. Lancet 2003;361:1533-44.
14. Christ G, Graf S, Huber-Beckmann R, Zorn G, Irene L, Kneussl M, et al. Impairment of the plasmin activation system in primary pulmonary hypertension: Evidence for gender differences. Thromb Haemost 2001;86:557-62
15. Hoeper MM, Sosada M, Fabe H. Plasma coagulation profiles in patients with severe primary pulmonary hypertension. Eur Respir J 1998;12:1446-9.